Rare Disease
Rare Disease
Rare Disease
Rare diseases impact over 300 million people worldwide, yet they remain significantly underdiagnosed and undertreated.
TrilliumBiO has a proven track record of addressing complex diagnostic challenges, including those associated with rare disease. TrilliumBiO develops niche diagnostics, by prioritizing and understanding the needs of the patient and provider. We partner to increase awareness and access in the rare disease community.
10,000+ distinct types of Rare and Genetic Diseases with 1 in 10 People are Affected by Rare Disease
95% of Rare Diseases Lack an FDA Approved Treatment
The economic impact of a delayed diagnosis can be over $500,000 in avoidable costs per patient
Faster & More Accurate Diagnosis – Over 50% of rare disease patients face diagnostic delays of 5-7 years. Improved testing reduces the diagnostic odyssey.
When you work with TrilliumBiO…
- Accelerated and customized rare disease assay development with industry experts, utilizing state of the art innovation
- We have experience pairing a partner’s therapeutic with biomarker testing/diagnostics as a component of being granted US Food and Drug Administration approval
- Establish trusted partnerships with foundations and patient advocacy groups to drive awareness of the need for appropriate screening and diagnostic testing
- Increasing patient & provider access through various innovations such as creative sample collection/shipping; free testing; EMR integration; at home test collection
We focus on what matters to individuals, families, and advocates in the rare disease community. Our solutions are physician-guided, offering unmatched expertise in diagnostics and personalized testing.
